Literature DB >> 31540955

The Parkinson's disease gene PINK1 activates Akt via PINK1 kinase-dependent regulation of the phospholipid PI(3,4,5)P3.

Rachel M Furlong1,2,3, Andrew Lindsay1, Karen E Anderson4, Phillip T Hawkins4, Aideen M Sullivan2,3, Cora O'Neill5,3.   

Abstract

Akt signalling is central to cell survival, metabolism, protein and lipid homeostasis, and is impaired in Parkinson's disease (PD). Akt activation is reduced in the brain in PD, and by many PD-causing genes, including PINK1 This study investigated the mechanisms by which PINK1 regulates Akt signalling. Our results reveal for the first time that PINK1 constitutively activates Akt in a PINK1-kinase dependent manner in the absence of growth factors, and enhances Akt activation in normal growth medium. In PINK1-modified MEFs, agonist-induced Akt signalling failed in the absence of PINK1, due to PINK1 kinase-dependent increases in PI(3,4,5)P3 at both plasma membrane and Golgi being significantly impaired. In the absence of PINK1, PI(3,4,5)P3 levels did not increase in the Golgi, and there was significant Golgi fragmentation, a recognised characteristic of PD neuropathology. PINK1 kinase activity protected the Golgi from fragmentation in an Akt-dependent fashion. This study demonstrates a new role for PINK1 as a primary upstream activator of Akt via PINK1 kinase-dependent regulation of its primary activator PI(3,4,5)P3, providing novel mechanistic information on how loss of PINK1 impairs Akt signalling in PD.This article has an associated First Person interview with the first author of the paper.
© 2019. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Akt; PINK1; PIP3; Parkinson's disease; neurodegeneration

Mesh:

Substances:

Year:  2019        PMID: 31540955     DOI: 10.1242/jcs.233221

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

1.  Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease.

Authors:  Mónica Tomás; Emma Martínez-Alonso; Narcisa Martínez-Martínez; Mireia Cara-Esteban; José A Martínez-Menárguez
Journal:  Histol Histopathol       Date:  2020-10-20       Impact factor: 2.303

2.  PINK1: Multiple mechanisms of neuroprotection.

Authors:  Britney N Lizama; P Anthony Otero; Charleen T Chu
Journal:  Int Rev Mov Disord       Date:  2021-10-04

3.  Role of Akt isoforms in neuronal insulin signaling and resistance.

Authors:  Medha Sharma; Chinmoy Sankar Dey
Journal:  Cell Mol Life Sci       Date:  2021-11-01       Impact factor: 9.261

4.  Deciphering the dual role and prognostic potential of PINK1 across cancer types.

Authors:  Katherine Dai; Daniel P Radin; Donna Leonardi
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

Review 5.  Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation.

Authors:  Margaret L Hibbs; Bridgette D Semple; Erskine Chu; Richelle Mychasiuk
Journal:  J Neuroinflammation       Date:  2021-11-27       Impact factor: 8.322

6.  Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson's disease.

Authors:  Gabriela Novak; Dimitrios Kyriakis; Kamil Grzyb; Michela Bernini; Sophie Rodius; Gunnar Dittmar; Steven Finkbeiner; Alexander Skupin
Journal:  Commun Biol       Date:  2022-01-13

7.  Rosmarinic Acid Attenuates Rotenone-Induced Neurotoxicity in SH-SY5Y Parkinson's Disease Cell Model through Abl Inhibition.

Authors:  Xiao Han; Bing Han; Yue Zhao; Gang Li; Tian Wang; Jie He; Wenxiao Du; Xiaolin Cao; Jing Gan; Zhenhua Wang; Wei Zheng
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

8.  Cleaved PINK1 induces neuronal plasticity through PKA-mediated BDNF functional regulation.

Authors:  Smijin K Soman; David Tingle; Raul Y Dagda; Mariana Torres; Marisela Dagda; Ruben K Dagda
Journal:  J Neurosci Res       Date:  2021-05-27       Impact factor: 4.433

9.  Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells.

Authors:  Gang Cheng; Micael Hardy; Jacek Zielonka; Katherine Weh; Monika Zielonka; Kathleen A Boyle; Mahmoud Abu Eid; Donna McAllister; Brian Bennett; Laura A Kresty; Michael B Dwinell; Balaraman Kalyanaraman
Journal:  Cancer Treat Res Commun       Date:  2020-09-17

Review 10.  An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson's Disease.

Authors:  Meir Schechter; Ronit Sharon
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.